Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
Smoking in schizophrenic patients: A critique of the self-medication hypothesis.

World journal of psychiatry

Manzella F, Maloney SE, Taylor GT.
PMID: 25815253
World J Psychiatry. 2015 Mar 22;5(1):35-46. doi: 10.5498/wjp.v5.i1.35.

A common remark among laypeople, and notably also among mental health workers, is that individuals with mental illnesses use drugs as self-medication to allay clinical symptoms and the side effects of drug treatments. Roots of the self-medication concept in...

Cite
Manzella F, Maloney SE, Taylor GT. Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World J Psychiatry. 2015;5(1):35-46doi: 10.5498/wjp.v5.i1.35.
Manzella, F., Maloney, S. E., & Taylor, G. T. (2015). Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World journal of psychiatry, 5(1), 35-46. https://doi.org/10.5498/wjp.v5.i1.35
Manzella, Francesca, et al. "Smoking in schizophrenic patients: A critique of the self-medication hypothesis." World journal of psychiatry vol. 5,1 (2015): 35-46. doi: https://doi.org/10.5498/wjp.v5.i1.35
Manzella F, Maloney SE, Taylor GT. Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World J Psychiatry. 2015 Mar 22;5(1):35-46. doi: 10.5498/wjp.v5.i1.35. PMID: 25815253; PMCID: PMC4369547.
Copy Download .nbib Format: NLM
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.

Cancers

Galanina N, Bejar R, Choi M, Goodman A, Wieduwilt M, Mulroney C, Kim L, Yeerna H, Tamayo P, Vergilio JA, Mughal TI, Miller V, Jamieson C, Kurzrock R.
PMID: 30583461
Cancers (Basel). 2018 Dec 21;11(1). doi: 10.3390/cancers11010011.

No abstract available.

Cite
Galanina N, Bejar R, Choi M, et al. Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers (Basel). 2018;11(1)doi: 10.3390/cancers11010011.
Galanina, N., Bejar, R., Choi, M., Goodman, A., Wieduwilt, M., Mulroney, C., Kim, L., Yeerna, H., Tamayo, P., Vergilio, J. A., Mughal, T. I., Miller, V., Jamieson, C., & Kurzrock, R. (2018). Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers, 11(1), . https://doi.org/10.3390/cancers11010011
Galanina, Natalie, et al. "Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials." Cancers vol. 11,1 (2018). doi: https://doi.org/10.3390/cancers11010011
Galanina N, Bejar R, Choi M, Goodman A, Wieduwilt M, Mulroney C, Kim L, Yeerna H, Tamayo P, Vergilio JA, Mughal TI, Miller V, Jamieson C, Kurzrock R. Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers (Basel). 2018 Dec 21;11(1). doi: 10.3390/cancers11010011. PMID: 30583461; PMCID: PMC6356731.
Copy Download .nbib Format: NLM
Acute Appendicitis Review: Background, Epidemiology, Diagnosis, and Treatment.

Cureus

Krzyzak M, Mulrooney SM.
PMID: 32670699
Cureus. 2020 Jun 11;12(6):e8562. doi: 10.7759/cureus.8562.

Appendicitis is a common occurrence in both the adult and pediatric populations. The condition most commonly occurs between the ages of 10 and 20 years with a lifetime risk of 8.6% and 6.7% for males and females respectively. Its...

Cite
Krzyzak M, Mulrooney SM. Acute Appendicitis Review: Background, Epidemiology, Diagnosis, and Treatment. Cureus. 2020;12(6):e8562doi: 10.7759/cureus.8562.
Krzyzak, M., & Mulrooney, S. M. (2020). Acute Appendicitis Review: Background, Epidemiology, Diagnosis, and Treatment. Cureus, 12(6), e8562. https://doi.org/10.7759/cureus.8562
Krzyzak, Michael, and Mulrooney, Stephen M. "Acute Appendicitis Review: Background, Epidemiology, Diagnosis, and Treatment." Cureus vol. 12,6 (2020): e8562. doi: https://doi.org/10.7759/cureus.8562
Krzyzak M, Mulrooney SM. Acute Appendicitis Review: Background, Epidemiology, Diagnosis, and Treatment. Cureus. 2020 Jun 11;12(6):e8562. doi: 10.7759/cureus.8562. PMID: 32670699; PMCID: PMC7358958.
Copy Download .nbib Format: NLM
Computational methods for RNA modification detection from nanopore direct RNA sequencing data.

RNA biology

Furlan M, Delgado-Tejedor A, Mulroney L, Pelizzola M, Novoa EM, Leonardi T.
PMID: 34559589
RNA Biol. 2021 Oct 15;18:31-40. doi: 10.1080/15476286.2021.1978215. Epub 2021 Sep 24.

The covalent modification of RNA molecules is a pervasive feature of all classes of RNAs and has fundamental roles in the regulation of several cellular processes. Mapping the location of RNA modifications transcriptome-wide is key to unveiling their role...

Cite
Furlan M, Delgado-Tejedor A, Mulroney L, et al. Computational methods for RNA modification detection from nanopore direct RNA sequencing data. RNA Biol. 2021;18:31-40doi: 10.1080/15476286.2021.1978215.
Furlan, M., Delgado-Tejedor, A., Mulroney, L., Pelizzola, M., Novoa, E. M., & Leonardi, T. (2021). Computational methods for RNA modification detection from nanopore direct RNA sequencing data. RNA biology, 1831-40. https://doi.org/10.1080/15476286.2021.1978215
Furlan, Mattia, et al. "Computational methods for RNA modification detection from nanopore direct RNA sequencing data." RNA biology vol. 18 (2021): 31-40. doi: https://doi.org/10.1080/15476286.2021.1978215
Furlan M, Delgado-Tejedor A, Mulroney L, Pelizzola M, Novoa EM, Leonardi T. Computational methods for RNA modification detection from nanopore direct RNA sequencing data. RNA Biol. 2021 Oct 15;18:31-40. doi: 10.1080/15476286.2021.1978215. Epub 2021 Sep 24. PMID: 34559589.
Copy Download .nbib Format: NLM
Severe de novo Ulcerative Colitis following Ixekizumab Therapy.

Case reports in gastroenterology

Philipose J, Ahmed M, Idiculla PS, Mulrooney SM, Gumaste VV.
PMID: 30483039
Case Rep Gastroenterol. 2018 Oct 17;12(3):617-621. doi: 10.1159/000493922. eCollection 2018.

Ixekizumab is a selective monoclonal antibody targeting interleukin-17A, approved for the treatment of chronic plaque psoriasis. It has rarely been associated with inflammatory bowel disease (IBD) in randomized trials only. We report a unique case of severe new-onset ulcerative...

Cite
Philipose J, Ahmed M, Idiculla PS, et al. Severe de novo Ulcerative Colitis following Ixekizumab Therapy. Case Rep Gastroenterol. 2018;12(3):617-621doi: 10.1159/000493922.
Philipose, J., Ahmed, M., Idiculla, P. S., Mulrooney, S. M., & Gumaste, V. V. (2018). Severe de novo Ulcerative Colitis following Ixekizumab Therapy. Case reports in gastroenterology, 12(3), 617-621. https://doi.org/10.1159/000493922
Philipose, Jobin, et al. "Severe de novo Ulcerative Colitis following Ixekizumab Therapy." Case reports in gastroenterology vol. 12,3 (2018): 617-621. doi: https://doi.org/10.1159/000493922
Philipose J, Ahmed M, Idiculla PS, Mulrooney SM, Gumaste VV. Severe de novo Ulcerative Colitis following Ixekizumab Therapy. Case Rep Gastroenterol. 2018 Oct 17;12(3):617-621. doi: 10.1159/000493922. eCollection 2018. PMID: 30483039; PMCID: PMC6244035.
Copy Download .nbib Format: NLM
Roth Net-Assisted Endoscopic-Guided Manometry Catheter Placement.

Cureus

Gurala D, Philipose J, Polavarapu AD, El Douaihy Y, Mulrooney SM.
PMID: 32999786
Cureus. 2020 Aug 26;12(8):e10063. doi: 10.7759/cureus.10063.

High-resolution esophageal manometry (HRM) has become the gold standard to diagnose esophageal motility disorders. Usually, this procedure is performed by introducing the catheter, which has pressure sensors, into the esophagus and proximal stomach via the nares. Repeated coiling of...

Cite
Gurala D, Philipose J, Polavarapu AD, et al. Roth Net-Assisted Endoscopic-Guided Manometry Catheter Placement. Cureus. 2020;12(8):e10063doi: 10.7759/cureus.10063.
Gurala, D., Philipose, J., Polavarapu, A. D., El Douaihy, Y., & Mulrooney, S. M. (2020). Roth Net-Assisted Endoscopic-Guided Manometry Catheter Placement. Cureus, 12(8), e10063. https://doi.org/10.7759/cureus.10063
Gurala, Dhineshreddy, et al. "Roth Net-Assisted Endoscopic-Guided Manometry Catheter Placement." Cureus vol. 12,8 (2020): e10063. doi: https://doi.org/10.7759/cureus.10063
Gurala D, Philipose J, Polavarapu AD, El Douaihy Y, Mulrooney SM. Roth Net-Assisted Endoscopic-Guided Manometry Catheter Placement. Cureus. 2020 Aug 26;12(8):e10063. doi: 10.7759/cureus.10063. PMID: 32999786; PMCID: PMC7520403.
Copy Download .nbib Format: NLM
Computational methods for RNA modification detection from nanopore direct RNA sequencing data.

RNA biology

Furlan M, Delgado-Tejedor A, Mulroney L, Pelizzola M, Novoa EM, Leonardi T.
PMID: 34559589
RNA Biol. 2021 Oct 15;18:31-40. doi: 10.1080/15476286.2021.1978215. Epub 2021 Sep 24.

The covalent modification of RNA molecules is a pervasive feature of all classes of RNAs and has fundamental roles in the regulation of several cellular processes. Mapping the location of RNA modifications transcriptome-wide is key to unveiling their role...

Cite
Furlan M, Delgado-Tejedor A, Mulroney L, et al. Computational methods for RNA modification detection from nanopore direct RNA sequencing data. RNA Biol. 2021;18:31-40doi: 10.1080/15476286.2021.1978215.
Furlan, M., Delgado-Tejedor, A., Mulroney, L., Pelizzola, M., Novoa, E. M., & Leonardi, T. (2021). Computational methods for RNA modification detection from nanopore direct RNA sequencing data. RNA biology, 1831-40. https://doi.org/10.1080/15476286.2021.1978215
Furlan, Mattia, et al. "Computational methods for RNA modification detection from nanopore direct RNA sequencing data." RNA biology vol. 18 (2021): 31-40. doi: https://doi.org/10.1080/15476286.2021.1978215
Furlan M, Delgado-Tejedor A, Mulroney L, Pelizzola M, Novoa EM, Leonardi T. Computational methods for RNA modification detection from nanopore direct RNA sequencing data. RNA Biol. 2021 Oct 15;18:31-40. doi: 10.1080/15476286.2021.1978215. Epub 2021 Sep 24. PMID: 34559589.
Copy Download .nbib Format: NLM
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome.

Transplantation and cellular therapy

Singh A, Dandoy CE, Chen M, Kim S, Mulroney CM, Kharfan-Dabaja MA, Ganguly S, Maziarz RT, Kanakry CG, Kanakry JA, Patel SS, Hill JA, De Oliveir S, Taplitz R, Hematti P, Lazarus HM, Abid MB, Goldsmith SR, Romee R, Komanduri KV, Badawy SM, Friend BD, Beitinjaneh A, Politikos I, Perales MA, Riches M.
PMID: 34587551
Transplant Cell Ther. 2021 Sep 26; doi: 10.1016/j.jtct.2021.09.015. Epub 2021 Sep 26.

The use of post-transplantation cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis in recipients of haploidentical and fully matched transplantations is on the increase. Published studies have reported an increased incidence of cytomegalovirus (CMV) infection with the use of PTCy....

Cite
Singh A, Dandoy CE, Chen M, et al. Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome. Transplant Cell Ther. 2021;doi: 10.1016/j.jtct.2021.09.015.
Singh, A., Dandoy, C. E., Chen, M., Kim, S., Mulroney, C. M., Kharfan-Dabaja, M. A., Ganguly, S., Maziarz, R. T., Kanakry, C. G., Kanakry, J. A., Patel, S. S., Hill, J. A., De Oliveir, S., Taplitz, R., Hematti, P., Lazarus, H. M., Abid, M. B., Goldsmith, S. R., Romee, R., Komanduri, K. V., Badawy, S. M., Friend, B. D., Beitinjaneh, A., Politikos, I., Perales, M. A., & Riches, M. (2021). Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome. Transplantation and cellular therapy, . https://doi.org/10.1016/j.jtct.2021.09.015
Singh, Anurag, et al. "Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome." Transplantation and cellular therapy vol. (2021). doi: https://doi.org/10.1016/j.jtct.2021.09.015
Singh A, Dandoy CE, Chen M, Kim S, Mulroney CM, Kharfan-Dabaja MA, Ganguly S, Maziarz RT, Kanakry CG, Kanakry JA, Patel SS, Hill JA, De Oliveir S, Taplitz R, Hematti P, Lazarus HM, Abid MB, Goldsmith SR, Romee R, Komanduri KV, Badawy SM, Friend BD, Beitinjaneh A, Politikos I, Perales MA, Riches M. Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome. Transplant Cell Ther. 2021 Sep 26; doi: 10.1016/j.jtct.2021.09.015. Epub 2021 Sep 26. PMID: 34587551.
Copy Download .nbib Format: NLM
Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model.

Genes, brain, and behavior

Nygaard KR, Swift RG, Glick RM, Wagner RE, Maloney SE, Gould GG, Dougherty JD.
PMID: 33978321
Genes Brain Behav. 2021 May 12;e12750. doi: 10.1111/gbb.12750. Epub 2021 May 12.

Williams Syndrome results in distinct behavioral phenotypes, which include learning deficits, anxiety, increased phobias and hypersociability. While the underlying mechanisms driving this subset of phenotypes is unknown, oxytocin (OT) dysregulation is hypothesized to be involved as some studies have...

Cite
Nygaard KR, Swift RG, Glick RM, et al. Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model. Genes Brain Behav. 2021;e12750doi: 10.1111/gbb.12750.
Nygaard, K. R., Swift, R. G., Glick, R. M., Wagner, R. E., Maloney, S. E., Gould, G. G., & Dougherty, J. D. (2021). Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model. Genes, brain, and behavior, e12750. https://doi.org/10.1111/gbb.12750
Nygaard, Kayla R, et al. "Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model." Genes, brain, and behavior vol. (2021): e12750. doi: https://doi.org/10.1111/gbb.12750
Nygaard KR, Swift RG, Glick RM, Wagner RE, Maloney SE, Gould GG, Dougherty JD. Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model. Genes Brain Behav. 2021 May 12;e12750. doi: 10.1111/gbb.12750. Epub 2021 May 12. PMID: 33978321.
Copy Download .nbib Format: NLM
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma.

Frontiers in oncology

Wang HY, Sokol ES, Goodman AM, Feldman AL, Mulroney CM.
PMID: 33777766
Front Oncol. 2021 Mar 10;11:620435. doi: 10.3389/fonc.2021.620435. eCollection 2021.

The pathogenesis of follicular lymphoma is a multi-step process, in which chromosomal translocation between immunoglobulin heavy chain (IgH) and anti-apoptotic B-cell lymphoma 2 (BCL2), namely IgH-BCL2, is an earliest step, followed by other genetic/genomic alterations including but not limited...

Cite
Wang HY, Sokol ES, Goodman AM, et al. Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. Front Oncol. 2021;11:620435doi: 10.3389/fonc.2021.620435.
Wang, H. Y., Sokol, E. S., Goodman, A. M., Feldman, A. L., & Mulroney, C. M. (2021). Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. Frontiers in oncology, 11620435. https://doi.org/10.3389/fonc.2021.620435
Wang, Huan-You, et al. "Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma." Frontiers in oncology vol. 11 (2021): 620435. doi: https://doi.org/10.3389/fonc.2021.620435
Wang HY, Sokol ES, Goodman AM, Feldman AL, Mulroney CM. Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. Front Oncol. 2021 Mar 10;11:620435. doi: 10.3389/fonc.2021.620435. eCollection 2021. PMID: 33777766; PMCID: PMC7988195.
Copy Download .nbib Format: NLM
Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies.

JCO precision oncology

Goodman AM, Choi M, Wieduwilt M, Mulroney C, Costello C, Frampton G, Miller V, Kurzrock R.
PMID: 28681041
JCO Precis Oncol. 2017 Jun;1. doi: 10.1200/PO.16.00004. Epub 2017 Apr 27.

Next generation sequencing (NGS) identifies alterations that may be potentially targetable by Food and Drug Administration (FDA) approved drugs and/or by available experimental agents that may not have otherwise been contemplated. Many targeted drugs have been developed for diverse...

Cite
Goodman AM, Choi M, Wieduwilt M, et al. Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO Precis Oncol. 2017;1doi: 10.1200/PO.16.00004.
Goodman, A. M., Choi, M., Wieduwilt, M., Mulroney, C., Costello, C., Frampton, G., Miller, V., & Kurzrock, R. (2017). Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO precision oncology, 1. https://doi.org/10.1200/PO.16.00004
Goodman, Aaron M, et al. "Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies." JCO precision oncology vol. 1 (2017). doi: https://doi.org/10.1200/PO.16.00004
Goodman AM, Choi M, Wieduwilt M, Mulroney C, Costello C, Frampton G, Miller V, Kurzrock R. Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO Precis Oncol. 2017 Jun;1. doi: 10.1200/PO.16.00004. Epub 2017 Apr 27. PMID: 28681041; PMCID: PMC5495179.
Copy Download .nbib Format: NLM
Author Correction: Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae.

Scientific reports

Mulroney KT, Hall JM, Huang X, Turnbull E, Bzdyl NM, Chakera A, Naseer U, Corea EM, Ellington MJ, Hopkins KL, Wester AL, Ekelund O, Woodford N, Inglis TJJ.
PMID: 29686361
Sci Rep. 2018 Apr 24;8(1):6697. doi: 10.1038/s41598-018-25216-y.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Cite
Mulroney KT, Hall JM, Huang X, et al. Author Correction: Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae. Sci Rep. 2018;8(1):6697doi: 10.1038/s41598-018-25216-y.
Mulroney, K. T., Hall, J. M., Huang, X., Turnbull, E., Bzdyl, N. M., Chakera, A., Naseer, U., Corea, E. M., Ellington, M. J., Hopkins, K. L., Wester, A. L., Ekelund, O., Woodford, N., & Inglis, T. J. J. (2018). Author Correction: Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae. Scientific reports, 8(1), 6697. https://doi.org/10.1038/s41598-018-25216-y
Mulroney, K T, et al. "Author Correction: Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae." Scientific reports vol. 8,1 (2018): 6697. doi: https://doi.org/10.1038/s41598-018-25216-y
Mulroney KT, Hall JM, Huang X, Turnbull E, Bzdyl NM, Chakera A, Naseer U, Corea EM, Ellington MJ, Hopkins KL, Wester AL, Ekelund O, Woodford N, Inglis TJJ. Author Correction: Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae. Sci Rep. 2018 Apr 24;8(1):6697. doi: 10.1038/s41598-018-25216-y. PMID: 29686361; PMCID: PMC5913273.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries